Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell × magrolimab × 1 year × Clear all

Sponsor

Conditions

Squamous Cell Carcinoma of Head and Neck 2 Leukemia, Myeloid, Acute 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Solid Tumor 1 Sezary Syndrome 1 Osteosarcoma 1 Neuroblastoma 1 Mycosis Fungoides 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Hodgkin Disease 1 Colorectal Neoplasms 1 Carcinoma, Transitional Cell 1 Brain Neoplasms 1

Interventions

Cyclophosphamide 46 fludarabine 29 Rituximab 28 Doxorubicin 13 Prednisone 12 Magnetic Resonance Spectroscopy 12 fludarabine phosphate 11 Vincristine 11 Specimen Handling 11 Bendamustine Hydrochloride 10 pirtobrutinib 9 Lenalidomide 9 Etoposide 9 Biopsy 8 pembrolizumab 7 obinutuzumab 7 zanubrutinib 6 venetoclax 6 polatuzumab vedotin 5 glofitamab 5 Leukapheresis 5 Immunotherapy, Adoptive 5 tazemetostat 4 tafasitamab 4 ibrutinib 4 etoposide phosphate 4 Nivolumab 4 Injections 4 CT-P10 4 loncastuximab tesirine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡